多重与单个动脉冠状动脉旁路移植手术的趋势和结果的比较
Qiuju Ding1, Han Li1, Xiaofeng Cheng1,2
1Department of Cardio-Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.
Frontiers in cardiovascular medicine
|November 21, 2025
概括
冠状动脉旁路移植 (CABG) 中的多重动脉移植 (MAG) 与单个动脉移植 (SAG) 相比,没有显著的短期结果差异. 慢性功能衰竭预测了不良事件,而良好的左心室功能是保护性的.
科学领域:
- 心血管外科心血管外科
- 胸部外科手术 胸部外科手术
- 医学研究 医学研究
背景情况:
- 多重动脉移植 (MAG) 建议用于冠状动脉旁路移植 (CABG) 的长期存活.
- 与单个动脉移植 (SAG) 相比,MAG的短期益处需要进一步研究.
- 了解与MAG相关的住院结果和风险因素至关重要.
研究的目的:
- 分析MAG在CABG后对住院结果的影响.
- 为了确定影响MAG患者短期结果的潜在风险因素.
- 为了比较MAG和SAG程序之间的医院治疗结果.
主要方法:
- 从2022年1月到2024年12月接受CABG的960名患者的回顾性分析.
- 一般化混合效应模型和灵敏度分析,以评估移植类型的影响.
- 评估主要心脏和脑血管不良事件 (MACCE),术后透析,IABP使用,再胸切除术和胸伤口感染 (SWI).
主要成果:
- 在MAG和SAG组之间,医院内MACCE,透析,IABP使用,再胸切除术或SWI没有显著差异.
- 接受MAG治疗的患者有更多的术前冠状动脉病变.
- 良好的左心室功能与术后透析,MACCE和IABP使用减少相关.
- 慢性功能衰竭是主要住院不良事件的预测因素.
结论:
- 这项单一中心研究发现,MAG和SAG在CABG患者中没有显著的短期结果差异.
- 研究结果应谨慎地应用于不同的临床环境和患者群体.
- 多中心,前性随机对照试验 (RCT) 是必要的,以验证这些结果.
更多相关视频
09:04Synergizing Antegrade Endoscopic with Bridging Vein Harvesting for Improvement of Great Saphenous Vein Graft Quality from the Lower Leg
Published on: November 19, 2019
9.1K
12:00Evaluation of a Novel Laser-assisted Coronary Anastomotic Connector - the Trinity Clip - in a Porcine Off-pump Bypass Model
Published on: November 24, 2014
15.8K
相关概念视频
01:20Comparing the Survival Analysis of Two or More Groups
541
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
541
01:27Coronary Artery Disease V: Interprofessional Care
206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206